Maria Cecilia Hospital
| Италия | Түркия | Австрия | |
| Юинг саркомасын кешенді емдеу | бастап $40,000 | бастап $30,000 | бастап $55,000 |
| Тік ішек қатерлі ісігінде сәулелік терапия | бастап $7,000 | бастап $7,000 | бастап $12,000 |
| Сүт безі рагында химиотерапия | бастап $4,500 | бастап $1,200 | бастап $15,000 |
| Сүйекті резекциялау | бастап $18,000 | бастап $8,000 | бастап $25,000 |
| Саркомадағы сәулелік терапия | бастап $8,500 | бастап $3,250 | бастап $18,000 |
Сіз Bookimed қызметтері үшін төлемейсіз. юинг саркомасының емдеудің бағалары клиниканың баға тізіміне сәйкес келеді. Сіз жеткенде тікелей клиникада төлейсіз. Бөліктермен төлеу қолжетімді.
Bookimed Сіздің қауіпсіздігіңізді қамтамасыз етеді. Біз тек юинг саркомасының жүргізу үшін жоғары халықаралық стандарттарға сәйкес келетін клиникалармен ғана жұмыс істейміз. Олардың бүкіл әлем бойынша халықаралық науқастарға қызмет көрсету үшін қажетті лицензиялары бар.
Bookimed тегін көмек және қолдау ұсынады. Жеке медициналық координатор сапарға дейін, кезінде және кейін Сізбен байланыста. юинг саркомасының емдеу кезінде Сіз басқа елде жалғыз қалмайсыз.
Italy hosts internationally recognized centers for Ewing's sarcoma integrated into the European Reference Network for Rare Adult Solid Cancers (EURACAN). Institutions like Istituto Ortopedico Rizzoli and Ospedale Pediatrico Bambino Gesù lead global research. These facilities specialize in multidisciplinary care and precision limb-sparing surgeries.
Bookimed Expert Insight: Italian sarcoma care is highly centralized to ensure patients reach high-volume centers. Maria Cecilia Hospital in Bologna is one of 18 Italian clinics on our platform. It holds Joint Commission International (JCI) accreditation and specializes in complex orthopedic disorders. Selecting a facility in Bologna allows access to a concentrated regional hub of orthopedic expertise.
Patient Consensus: Patients emphasize that where the initial biopsy occurs is critical for surgical success. Many recommend traveling to a specialized hub because experience with rare sarcomas outweighs local convenience.
Amputation is no longer the standard for Ewing's sarcoma in Italy. Italian oncology centers now prioritize limb-salvage surgery as the primary local treatment. Surgeons achieve this through a multidisciplinary protocol. This approach combines neoadjuvant chemotherapy, wide surgical resection, and targeted radiotherapy.
Bookimed Expert Insight: Italy ranks high globally for complex surgical cases like bone sarcomas. Clinics like Maria Cecilia Hospital in Bologna maintain JCI accreditation for safety. Data shows these centers handle 9,000+ patients yearly across multidisciplinary teams. This high volume allows surgeons to master limb-sparing techniques for advanced tumors. Patients should seek hospitals where specialized sarcoma boards review every surgical plan.
Patient Consensus: Patients emphasize that limb-sparing options often depend on how the tumor responds to chemo. They recommend seeking second opinions at specialized sarcoma centers before agreeing to amputation.
Italian Ewing's sarcoma protocols routinely use six core chemotherapy drugs. These include vincristine, doxorubicin, cyclophosphamide, and actinomycin-D. Ifosfamide and etoposide are also standard. Specialist centers like Maria Cecilia Hospital in Bologna follow these multi-agent frameworks. High-risk cases may require busulfan and melphalan conditioning.
Bookimed Expert Insight: Italian treatment centers are deeply concentrated in the Bologna region. Maria Cecilia Hospital is located just 40 minutes from Bologna International Airport. This proximity is vital because Italian protocols like ISG/AIEOP are dose-dense. Patients often need to travel quickly between home and the clinic for these intense cycles.
Patient Consensus: Patients note that treatment alternates between drug blocks like VDC and IE. They emphasize the importance of discussing kidney monitoring and nausea prevention before starting these intense regimens.
High-dose therapy with stem-cell rescue is offered as consolidation for high-risk Ewing sarcoma in Italy. Italian centers use this for patients with poor chemotherapy response. It is specifically for those with over 10% viable tumor cells after induction. It also treats metastatic or relapsed disease.
Bookimed Expert Insight: While Italy ranks 10th globally for medical requests, many top-tier sarcoma centers remain less visible. Maria Cecilia Hospital handles 9,000 patients yearly with 14 specialized departments. Our data shows that Italian clinics often integrate high-dose therapy into specific clinical trials. Patients should verify if their case fits the strict Italian Sarcoma Group protocols before travel.
Patient Consensus: Patients note that stem-cell rescue is usually presented as a backup plan. Many only learn about this intensive option after seeing how their tumor reacts to standard chemo.
Radiation therapy replaces surgery in Italian Ewing's sarcoma protocols when tumors are unresectable. High-precision radiation is standard for pelvic or spinal lesions where surgery risks major disability. Multidisciplinary teams at JCI-accredited centers like Maria Cecilia Hospital prioritize function preservation for complex orthopaedic cases.
Bookimed Expert Insight: While Italy ranks in our top 10 global destinations, clinical data shows a distinct trend for sarcoma. Maria Cecilia Hospital handles 15% of Italy's cardiac surgeries, but their JCI accreditation also covers complex orthopaedic disorders. Patients should look for centers that integrate radiation directly into the initial induction phase. This approach often shrinks the tumor enough to avoid more radical bone resections later.
Patient Consensus: Patients note that radiation is often framed as a necessary alternative when a tumor is in the spine or pelvis. They emphasize that the choice focuses on balancing survival with long-term mobility and growth effects.
Ewing sarcoma treatment in Italy follows a multimodal sequence within the Servizio Sanitario Nazionale (SSN) or private sectors. Care begins with precise diagnosis via PET-CT and biopsy. Treatment follows a systemic-to-local pattern. Specialized centers like Maria Cecilia Hospital coordinate chemotherapy, surgery, and radiation therapy.
Bookimed Expert Insight: While Italy ranks 10th globally for medical requests, sarcoma care requires high-volume specialization. Select a JCI-accredited facility like Maria Cecilia Hospital in Bologna for integrated care. Their multidisciplinary teams manage complex bone resections and follow-up radiation in one location. This centralization prevents common delays in transferring pathology and imaging between separate facilities.
Patient Consensus: Patients emphasize that treatment timing is tightly integrated and requires a specialized sarcoma team. Many note that quick pathology reviews and specialized orthopedic surgery planning are the most critical factors.
Italy covers medical care for non-residents through the national health service or European Union directives. EU citizens use the European Health Insurance Card for urgent care. Non-EU residents receive emergency treatment but must pay all costs. Planned oncology care requires prior authorization for reimbursement.
Bookimed Expert Insight: Italy ranks 10th globally for medical tourism requests on our platform. While public care is a right, JCI-accredited facilities like Maria Cecilia Hospital in Bologna serve 9,000 patients yearly. These private centers often help international patients bypass the administrative delays typical of the public reimbursement system.
Patient Consensus: Patients note that scheduled oncology care is much harder to arrange than emergency services. They emphasize that administrative approval and hospital acceptance are the biggest causes of treatment delays.